News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
704,386 Results
Type
Article (41293)
Company Profile (262)
Press Release (662831)
Multimedia
Podcasts (53)
Webinars (12)
Section
Business (205631)
Career Advice (2020)
Deals (35588)
Drug Delivery (99)
Drug Development (81585)
Employer Resources (172)
FDA (16335)
Job Trends (14940)
News (347712)
Policy (33006)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2600)
Accelerated approval (5)
Adcomms (21)
Allergies (86)
Alliances (50130)
ALS (89)
Alzheimer's disease (1391)
Antibody-drug conjugate (ADC) (126)
Approvals (16330)
Artificial intelligence (252)
Autoimmune disease (22)
Automation (16)
Bankruptcy (362)
Best Places to Work (11683)
BIOSECURE Act (21)
Biosimilars (111)
Biotechnology (186)
Bladder cancer (78)
Brain cancer (26)
Breast cancer (275)
Cancer (2246)
Cardiovascular disease (173)
Career advice (1686)
Career pathing (30)
CAR-T (147)
Cell therapy (422)
Cervical cancer (19)
Clinical research (66306)
Collaboration (834)
Compensation (522)
Complete response letters (21)
COVID-19 (2625)
CRISPR (39)
C-suite (236)
Cystic fibrosis (101)
Data (2165)
Decentralized trials (2)
Denatured (20)
Depression (42)
Diabetes (266)
Diagnostics (6399)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (122)
Drug pricing (101)
Drug shortages (25)
Duchenne muscular dystrophy (96)
Earnings (86659)
Editorial (37)
Employer branding (21)
Employer resources (146)
Events (112967)
Executive appointments (717)
FDA (17572)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (752)
Gene editing (103)
Generative AI (20)
Gene therapy (305)
GLP-1 (713)
Government (4515)
Grass and pollen (4)
Guidances (53)
Healthcare (18896)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (119)
Indications (30)
Infectious disease (2770)
Inflammatory bowel disease (139)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (95)
Interviews (312)
IPO (16565)
IRA (41)
Job creations (3671)
Job search strategy (1433)
Kidney cancer (10)
Labor market (38)
Layoffs (470)
Leadership (16)
Legal (7971)
Liver cancer (75)
Lung cancer (323)
Lymphoma (150)
Machine learning (6)
Management (58)
Manufacturing (306)
MASH (65)
Medical device (13438)
Medtech (13443)
Mergers & acquisitions (19553)
Metabolic disorders (675)
Multiple sclerosis (77)
NASH (16)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1914)
NextGen: Class of 2025 (6561)
Non-profit (4507)
Northern California (2633)
Now hiring (39)
Obesity (360)
Opinion (212)
Ovarian cancer (73)
Pain (83)
Pancreatic cancer (82)
Parkinson's disease (146)
Partnered (22)
Patents (234)
Patient recruitment (107)
Peanut (49)
People (57657)
Pharmaceutical (65)
Pharmacy benefit managers (18)
Phase I (20675)
Phase II (29177)
Phase III (21770)
Pipeline (1159)
Policy (141)
Postmarket research (2578)
Preclinical (8793)
Press Release (71)
Prostate cancer (105)
Psychedelics (31)
Radiopharmaceuticals (245)
Rare diseases (384)
Real estate (5997)
Recruiting (65)
Regulatory (22606)
Reports (46)
Research institute (2359)
Resumes & cover letters (350)
Rett syndrome (4)
RNA editing (4)
RSV (43)
Schizophrenia (68)
Series A (131)
Series B (85)
Service/supplier (11)
Sickle cell disease (54)
Southern California (2274)
Special edition (14)
Spinal muscular atrophy (149)
Sponsored (30)
Startups (3628)
State (2)
Stomach cancer (13)
Supply chain (67)
Tariffs (35)
The Weekly (31)
United States (22807)
Vaccines (708)
Venture capitalists (41)
Weight loss (232)
Women's health (35)
Worklife (15)
Date
Today (220)
Last 7 days (819)
Last 30 days (2528)
Last 365 days (33181)
2025 (10214)
2024 (35480)
2023 (40333)
2022 (51487)
2021 (56034)
2020 (54399)
2019 (46849)
2018 (35303)
2017 (32485)
2016 (31855)
2015 (37923)
2014 (31692)
2013 (26709)
2012 (28881)
2011 (29574)
2010 (27569)
Location
Africa (732)
Alabama (52)
Alaska (7)
Arizona (231)
Arkansas (13)
Asia (38520)
Australia (6268)
California (6023)
Canada (1987)
China (519)
Colorado (265)
Connecticut (271)
Delaware (142)
Europe (82785)
Florida (888)
Georgia (203)
Idaho (57)
Illinois (525)
India (25)
Indiana (308)
Iowa (11)
Japan (157)
Kansas (102)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (899)
Massachusetts (4516)
Michigan (216)
Minnesota (394)
Mississippi (2)
Missouri (82)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (62)
New Jersey (1704)
New Mexico (28)
New York (1715)
North Carolina (960)
North Dakota (8)
Northern California (2633)
Ohio (202)
Oklahoma (14)
Oregon (35)
Pennsylvania (1350)
Puerto Rico (11)
Rhode Island (32)
South America (1112)
South Carolina (22)
South Dakota (1)
Southern California (2274)
Tennessee (101)
Texas (887)
Utah (179)
Virginia (143)
Washington D.C. (62)
Washington State (546)
West Virginia (3)
Wisconsin (52)
704,386 Results for "prellis biologics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States
March 7, 2025
·
6 min read
Press Releases
NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate Update
April 10, 2025
·
15 min read
Business
Prellis Biologics Announces Collaboration with Sanofi
Prellis Biologics, Inc. (Prellis), a Bay Area biotherapeutics company, announced today that it has entered into a collaboration and license option agreement with Sanofi S.A. focused on the discovery of antibodies with Prellis’ first-in-class external human immune system (EXIS™).
March 22, 2022
·
2 min read
Press Releases
MustGrow Signs Exclusive Distribution Agreement with Adjuvants Plus Inc. for Biological Product Line
February 11, 2025
·
8 min read
Press Releases
HCW Biologics Inc. Received NASDAQ Staff Determination Letter
December 23, 2024
·
4 min read
Business
Prellis Biologics Announces Collaboration and License Agreement with Bristol Myers Squibb
Prellis Biologics, Inc. (Prellis), a Bay Area biotechnology company, announced today that it has entered into a multi-target drug discovery collaboration and licensing agreement with Bristol Myers Squibb.
January 13, 2022
·
2 min read
Press Releases
Vivex Biologics, Inc. Provides Enrollment Update for its ASCEND Study Examining Whether Supplementing Discs with VIA Disc NP™ Reduces Pain and/or Improves Function in Patients with Symptomatic Disc Degeneration
April 9, 2025
·
2 min read
Press Releases
ADMA Biologics Statement on Tariffs
April 8, 2025
·
4 min read
Press Releases
Bora Biologics Unveils Cutting-Edge Innovations at Festival of Biologics 2025
April 17, 2025
·
2 min read
Biotech Bay
Prellis Biologics Appoints New CEO, Raises $35 Million in Series C Funding to Leverage Human Immune System Biology to De-Risk and Accelerate Therapeutics Drug Discovery and Development
Prellis Biologics, Inc (Prellis Bio), a biotherapeutics company, today appointed Michael Nohaile, PhD as its new CEO and announced it has raised a $35 million Series C funding round.
August 10, 2022
·
5 min read
1 of 70,439
Next
